STOCKWATCH
·
Pharmaceuticals
Quarterly Result5 Aug 2025, 06:52 am

Natural Capsules Ltd Reports Q1FY26 Results with 15.36% EBIDTA Margin

AI Summary

Natural Capsules Limited, a leading manufacturer of hard capsules shell, has announced its financial results for the quarter ended June 30, 2025. The company reported a revenue of ₹ 45.20 Cr, an increase of ₹ 0.32 Cr from the previous quarter. The EBIDTA margin increased to 0.71% from 0.52% in the same period last year. The HPMC capsules segment saw robust demand due to US duties on Chinese HPMC capsules. The company plans to commercialise two additional production lines to capitalise on this demand. The API segment is showing signs of improvement with select APIs witnessing price increases.

Key Highlights

  • Revenue of ₹ 45.20 Cr, an increase of ₹ 0.32 Cr from the previous quarter
  • EBIDTA margin increased to 0.71% from 0.52% in the same period last year
  • Robust demand for HPMC capsules due to US duties on Chinese HPMC capsules
  • Plans to commercialise two additional production lines for HPMC capsules
  • Emerging signs of improvement in the API segment with select APIs witnessing price increases
NATCAPSUQ
Pharmaceuticals
NATURAL CAPSULES LTD.

Price Impact